Hot Stocks: Brokerages view on Kfin Tech, Sun Pharma, Pidilite and Exide
Morgan Stanley has given an 'overweight' rating to Sun Pharmaceuticals, citing several upcoming growth factors. JP Morgan has also rated Exide Industries and Kfin Technologies as 'overweight' and 'neutral', respectively, while Citi has a 'buy' rating on Exide. JP Morgan has given an 'underweight' rating to Pidilite Industries. The company's earnings missed expectations, but its gross margin recovered and the demand narrative was cautiously optimistic, it said.